ID: ALA5275332

Max Phase: Preclinical

Molecular Formula: C14H21NO3

Molecular Weight: 251.33

Associated Items:

Representations

Canonical SMILES:  Cc1cc(=O)c(O)c(CN2CC(C)CC(C)C2)o1

Standard InChI:  InChI=1S/C14H21NO3/c1-9-4-10(2)7-15(6-9)8-13-14(17)12(16)5-11(3)18-13/h5,9-10,17H,4,6-8H2,1-3H3

Standard InChI Key:  YIVMXVWQPWLGGP-UHFFFAOYSA-N

Associated Targets(non-human)

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 251.33Molecular Weight (Monoisotopic): 251.1521AlogP: 2.13#Rotatable Bonds: 2
Polar Surface Area: 53.68Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.63CX Basic pKa: 7.72CX LogP: 1.84CX LogD: 1.46
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.87Np Likeness Score: 0.00

References

1. He M, Fan M, Peng Z, Wang G..  (2021)  An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.,  221  [PMID:34023737] [10.1016/j.ejmech.2021.113546]

Source